Recombinant human C1 esterase inhibitor for the management of adverse events related to intravenous immunoglobulin infusion: A pilot open-label study

Melamed Isaac R.; Miranda Holly; Heffron Melinda; Harper Joe

首页> 外文期刊>Allergy and asthma proceedings >Recombinant human C1 esterase inhibitor for the management of adverse events related to intravenous immunoglobulin infusion: A pilot open-label study

【24h】

Recombinant human C1 esterase inhibitor for the management of adverse events related to intravenous immunoglobulin infusion: A pilot open-label study

机译：重组人C1酯酶抑制剂用于管理与静脉内免疫球蛋白输注相关的不良事件：飞行员开放标签研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Allergy and asthma proceedings》 |2020年第3期|共2页
作者
Melamed Isaac R.; Miranda Holly; Heffron Melinda; Harper Joe;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Recombinant human C1 esterase inhibitor for the management of adverse events related to intravenous immunoglobulin infusion: A pilot open-label study [J] . Melamed Isaac R., Miranda Holly, Heffron Melinda, Allergy and asthma proceedings . 2020,第3期

机译：重组人C1酯酶抑制剂用于管理与静脉内免疫球蛋白输注相关的不良事件：飞行员开放标签研究
2. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) [J] . Sabharwal Geetika, Craig Timothy Expert review of clinical immunology . 2015,第3期

机译：重组人C1酯酶抑制剂用于治疗由于C1抑制剂缺乏引起的遗传性血管性水肿（C1-INH-HAE）
3. Recombinant human C1 esterase inhibitor as routine short-term prophylaxis for prevention of hereditary angioedema attacks during menses in siblings [J] . Smith Andrew M., Park Nami Allergy and asthma proceedings . 2020,第3期

机译：重组人C1酯酶抑制剂作为预防在兄弟姐妹的月经期间预防遗传性血管后期攻击的常规短期预防
4. Risk- and Vulnerability Analyses in Crisis Management of Extreme Events - A Pilot Study [C] . Marcus Abrahamsson, Sven Erik Magnusson, Kurt Petersen International Conference on Probabilistic Safety Assessment and Management(PSAM7-ESREL'04) v.2; 20040614-20040618; Berlin; DE . 2004

机译：极端事件的危机管理中的风险和脆弱性分析-一项初步研究
5. Human Factors Contributing to Preventable Adverse Drug Events in Healthcare: A Grounded Theory Approach Pilot Study [D] . Hilgers, Thomas Ryan. 2018

机译：人为因素促成医疗保健中可预防的不良药物事件：一项扎根的理论方法试点研究
6. Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study [O] . Isaac R. Melamed, Holly Miranda, Melinda Heffron, 2021

机译：重组人C1酯酶抑制作用与常见可变免疫缺陷或多变疗效患者患者静脉内免疫球蛋白输注相关的不良事件：飞行员开放标签研究
7. A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions [O] . Singh‐Grewal, D, Kemp, A, Wong, M 2006

机译：静脉注射免疫球蛋白后立即和延迟不良事件的前瞻性研究

Recombinant human C1 esterase inhibitor for the management of adverse events related to intravenous immunoglobulin infusion: A pilot open-label study

著录项

引文网络

相似文献

相关主题

期刊订阅